1-Benzylpiperidine-4-Carbaldehyde

22065-85-6

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise t<hat is market-oriented and realizes industrial development through R&D innova tion and technology transformation.

key word:

Pharmaceutical technology

Category:

Product Description

Integrity, innovation, cooperation, sharing, win-win

The company integrates multiple resources and strives to build a large health industr×y finance platform company integrating pharmaceutical♥, intelligent medical, bio pharmaceutical R&D, industrial production and sales.

The chemical reactions involved in the existing products include Foucault react™ion, nitration reaction, sulfonation reaction, hydrogenation reaction, fluorination reactio₹n, chlorination reaction, bromination reaction, diazotization reaction, forma₩t reaction, etc.

Related products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP4) inhibitor de≤veloped by Merck. In October 2006, Sitagliptin phosphate Januvia was approved by FDA as th≠e first DPP4 inhibitor for the treatment of type ⅱ diabetes mellitus . The characteristics of this drug are that it can st✘imulate insulin secretion while reducing hunger without causing weight gain. Hypoglycemia and ede↔ma will not occur, and it is suitable for diabetic patients with poor blood g$lucose control and frequent hypoglycemia.

Sumatriptan Succinate

Medication for migraine

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech pharm↔aceutical enterprise that is market-oriented and realizes ✘industrial development through R&D innovation and technology transformation.

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is one of the♠ most important products for the treatment of arthritis. It is well tolerated and has a low• incidence of side effects

Pranlukast

Pranlukast, developed by Ono, is one of the three major leukotriene receptor antag"onists. In clinical application, it has good therapeutic effect on atopic asthma and other t<ypes of bronchial asthma, and the market prospect is huge. In the major category of asth ma drugs, leukotriene receptor antagonists have the fastest growing market share.

Avanafil

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise t∞hat is market-oriented and realizes industrial development through₩ R&D innovation and technology transformation.

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is the second drug a₽pproved by FDA for Alzheimer's disease in the United States. Its treatm→ent reaches the target dose and has low toxic and side effects. It has been widely recognized by o™ur medical community, and good tolerance is its biggest adv♣antage. In October 1999, Donepezil was launched in China under the traγde name "Aricept", which is the main chemical drug aga☆inst Alzheimer's disease. At present, CFDA has approved a number of domestic enterp¥rises to produce donepezil preparations, the main dosage forΩms are tablets, capsules, dispersive tablets, oral disintegrating tablets.

Almotriptan

Migraine medication for adolescents

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Apixaban (El✔iquis, Bristol-Myers Squibb/Pfizer), a direct oral factor Xa inhibitor, was approved for u≥se in the 27 EU member states. The world's first drug approved to prevent ven£ous thromboembolism (VTE) in adult patients undergoing elective hipα or knee replacement. From June 2019 to June 2020, the annual sales of apixaban products ove←rseas reached about $15.4 billion, with a year-on-year growth of neεarly 32%, and the API consumption reached about 23,960 kg, wi✔th a year-on-year growth of about 28%. Compared with its main competitor, Riv✘aroxaban, the drug's annual overseas sales are about $4.5 billion higher.

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharmace‌utical enterprise that is market-oriented and realizes industrial development t↕hrough R&D innovation and technology transformation.

Clofarabine

It is a nucleotide analogue developed by Bioenvision and manufactured by Genzyme. On December 29φ, 2004, it was approved by FDA for the treatment of refractory or relapsed acut‌e lymphoblastic leukemia (ALL) in children.

Upadacitinib(Scientific research)

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-o™riented and realizes industrial development through R&D innovation and technolog£y transformation.

Product Consulting

Our staff will contact you within 24 hours (working days). If you need other ser✘vices, E-mail: 2880705932@qq.com